G

Genentech

Biotech firm creating medicines via R&D

Principal Biostatistician

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-timeSouth San Francisco, CA, USA

About the Job

Requirements

  • You hold a PhD or MSc in Statistics, Biostatistics, or a closely related quantitative field.
  • You bring at least 6 years of experience in clinical trial statistics, including responsibility for study-level strategy and decision-making.
  • You have a proven ability to lead statistical input into clinical development plans and regulatory submissions.
  • You have strong expertise applying advanced statistical methods to enable data-driven decision-making.
  • You are proficient in SAS and/or R and deeply familiar with CDISC standards and evolving regulatory data requirements.

Responsibilities

  • You lead the statistical design of complex or high-priority early-phase studies, including adaptive, platform, and biomarker-enriched trials.
  • You champion the use of innovative methodologies, such as Bayesian designs and model-based dose selection, aligned with exploratory objectives and scientific hypotheses.
  • You ensure strategic alignment and quality across statistical deliverables within early-phase programs, shaping the statistical framework that supports phase transitions, internal governance reviews, and regulatory interactions.
  • You solve complex statistical challenges in early development using deep expertise and novel approaches, such as integrating translational data, navigating sparse or emerging datasets, and balancing speed with scientific rigor.
  • You interpret and drive the narrative around emerging data, translating early signals into clear, meaningful insights for internal stakeholders and external communications.
  • You own the statistical content of major early regulatory submissions, such as INDs, EMA scientific advice packages, and pre-IND or end-of-Phase-1 meetings, ensuring clarity, integrity, and scientific robustness.
  • You lead sub-streams and functional contributions within disease-area strategy and the integration of novel data sources, such as omics, imaging, and real-world data.
  • You maintain strong connectivity and collaboration with other core biometrics functions within PDD, including Biostatistics, Analytical Data Science, and Data Management, ensuring early-phase analysis strategies are executable.

Desired Qualifications

  • Extensive experience working in cross-functional, global early-development teams, with demonstrated ability to collaborate effectively across Clinical Development, Clinical Pharmacology, Translational Medicine, Regulatory, and Biomarker teams.
  • Effective communication skills, including the ability to translate complex or exploratory statistical methodologies into actionable insights for clinical, regulatory, and non-technical audiences.
  • Experience across multiple phases of drug development, with a strong emphasis on early-phase (Phase I/II) trials, including first-in-human, dose-finding, and proof-of-concept studies.
  • Excellent communication and influencing skills, with a proven track record of shaping clinical strategy, informing go/no-go decisions, and aligning statistical strategy with program goals.
  • Demonstrated scientific leadership and mentoring within a matrixed organizational structure, including guiding junior statisticians and cross-functional colleagues on the application of innovative design and analysis techniques.
  • Strategic mindset, with the ability to assess risk, anticipate data needs, and contribute to portfolio-level decisions, including dose/regimen optimization and early investment prioritization.
  • Familiarity with innovative methods, such as Bayesian adaptive design, MIDD, and complex modeling, and a working knowledge of evolving regulatory expectations and scientific trends relevant to early development.

About the Company

Genentech

Biotech firm creating medicines via R&D

Genentech develops medicines and therapies to address unmet medical needs through extensive biotechnology research and development. Its products include biologic and small-molecule treatments prescribed by healthcare providers and sold through partnerships with suppliers and health systems. It differentiates itself with a large R&D footprint, a vast patent portfolio, and FDA Breakthrough Therapy Designations that accelerate promising therapies. Its goal is to advance medical science and deliver high-quality, effective therapies that improve patient health while supporting the broader medical community.

Company size
10,001+
Company stage
IPO
Headquarters
San Francisco, CA
Founded
1976

Recently Posted Jobs

Explore more opportunities at Genentech

See more jobs